NICE | March 2020 | COVID-19 rapid guideline: delivery of radiotherapy [NG162]
The purpose of this guideline is to maximise the safety of patients who need radiotherapy and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for radiotherapy to patient needs if services become limited because of the COVID-19 pandemic.
This guidance was first published on 28 March 2020.
NICE has also produced a COVID-19 rapid guideline on delivery of systemic anticancer treatments.
This guideline is for:
- health and care practitioners
- health and care staff involved in planning and delivering services
The recommendations bring together
- existing national and international guidance and policies
- advice from specialists working in the NHS from across the UK. These include people with expertise and experience of treating patients for the specific health conditions covered by the guidance during the current COVID-19 pandemic.
Full details from NICE